Background. Pulsed radiofrequency (PRF) treatment offers pain relief for patients suffering from chronic pain who do not respond well to conventional treatments. We tested whether PRF treatment attenuated complete Freund's adjuvant (CFA)-induced inflammatory pain. Epigenetic modification of potassium-chloride cotransporter 2 (KCC2) gene
Introduction
There are currently two general categories of radiofrequency (RF) in use. Conventional radiofrequency (CRF) uses a constant output of high-frequency electrical current to produce temperatures between 60 C and 80 C, resulting in neuroablative thermocoagulation. Pulsed radiofrequency (PRF) utilizes brief "pulses" of high-voltage electric current (e.g., 20 minutes' pulses of 500 kHz) to produce the same voltage fluctuations in the region of treatment that occur during CRF treatment, but without heating to a degree at which tissue coagulates. Since the initial reports of PRF 18 years ago [1] , hundreds of publications have reported on the use of this modality for the management of various painful conditions such as radicular pain, facet joint pain, sacroiliac joint pain, and other chronic pain syndromes [2, 3] . Despite the large number of publications on the use of PRF, the clinical evidence for the use of PRF for pain management remains limited. This is due not only to the lack of large randomized controlled trials but also to an inadequate understanding of underlying pain and treatment mechanisms. To improve existing pain treatments, it is of pivotal importance to understand the mechanism of action of PRF. The cellular and molecular changes induced by PRF and their relationship to the treatment of the disease should be investigated and may, in turn, lead to more effective clinical use of PRF in the management of pain.
Most preclinical studies that investigate antinociceptive effects report on PRFs' possible mode of action in different animal neuropathic pain models [4] [5] [6] [7] [8] . Recent studies suggest that PRF may play a role in the treatment of inflammatory pain conditions [9, 10] . Hagiwara et al. first demonstrated that thermal hyperalgesia was attenuated by PRF application on L5 dorsal roots in rabbits with complete Freund's adjuvant (CFA) hind paw injection. The analgesic effects of PRF may involve the enhancement of noradrenergic and serotonergic descending inhibitory pathways [11] . Yang et al. observed that PRF applied proximally to the L5 DRG is an effective treatment for experimentally induced inflammatory pain through attenuation of mechanical allodynia by suppression of EAA-citrulline release in the spinal dorsal horn [10] . Chen et al. reported that PRF applied close to the L4 DRG significantly attenuated CFA-induced mechanical hyperalgesia by attenuating JNK activation in the spinal dorsal horn [9] . However, the complexity of the pathophysiological interrelationship between PRF and inflammatory pain is still not well understood.
Spinal dorsal horn is the first relay in the central nervous system (CNS), where nociceptive input from primary sensory afferents is integrated and further transmitted to higher brain centers. In rats, GABA immunoreactivity is present in about 25%, 30%, and 40% of neurons in laminae I, II, and III, respectively. Most of the glycineimmunoreactive cell bodies in laminae I-III are also GABA-immunoreactive, with the exception of some neurons in lamina III [12] . This abundance of inhibitory interneurons in the spinal cord strongly suggests an important functional role of inhibition in pain information processing. Accumulated evidence suggests that a disruption of spinal inhibitory circuit efficacy contributes to chronic pain development [13] [14] [15] . In the nervous system, the strength and polarity of inhibitory neurotransmission largely depend on the intracellular chloride concentration, which is determined, in part, by the activities of KCC2 [16] . A reduction in KCC2 gene expression after peripheral inflammation induced by CFA injection has also been reported, which can effectively eliminate inhibition mediated by GABA and glycine [17] . Our previous unpublished data demonstrated that a histone acetylation promoter plays a role in CFA-induced suppression of KCC2 in the spinal dorsal horn. In this study, we have examined the influence of PRF on histone acetylation at the KCC2 promoter in the spinal dorsal horn of CFA rats and inhibitory neurotransmission in terms of GlyR sIPSCs and GABAR sIPSCs change.
Methods

Animals
The study was reviewed and approved by the Chang Gung Memorial Hospital Animal Care and Use Committee (Kaohsiung, Taiwan). Male Sprague-Dawley rats (National Science Council, Taipei, Taiwan) weighing 150-200 g were studied. They were housed in standard cages in climate-and light-controlled rooms (12-hour light/dark cycle) at a temperature of 22 C with free access to food and water. To reduce the influence of handling on nociceptive responses, all animals were handled and trained for at least four to six days before testing. Inflammatory pain was induced in the unilateral hind paw by intradermal injection of 0.2 mL of CFA (Sigma, MO, USA) into the plantar surface of the left hind paw. Following experimentation, five animals were sacrificed at four hours, one day, three days, seven days, and 14 days post-CFA injection (N ¼ 5 for each group). The bilateral dorsal horns of the lumbar region of the rat spinal cords (L4-L5) were taken for Western blot analysis.
The rats were randomly assigned to four groups as follows:
Group NSþnoPRF: Rats were administered a saline intraplantar injection (0.2 mL) and received sciatic nerve exposure (N ¼ 30). Group NSþPRF: Rats were administered a saline intraplantar injection (0.2 mL) and received PRF (N ¼ 30). Group CFAþnoPRF: Rats were administered a CFA intraplantar injection (0.2 mL) and received sciatic nerve exposure (N ¼ 30). Group CFAþPRF: Rats were administered a CFA intraplantar injection (0.2 mL) and received PRF (N ¼ 30).
In the PRF groups, PRF was delivered adjacent to L5 and L6 DRG using a 10 cm electrode (22 G, 5 mm active tip; SMK-10, Radionics, Burlington, MA, USA) powered by a PRF generator (RF-5, Radionics) delivering 500 kHz electric current at two bursts per second (2 Hz) of 20 minutes' duration each. The generator output was increased automatically until an electrode tip temperature of 42 C and maintained for 120 seconds. In the sham-treated rats, identical electrode placement was performed, but no PRF electric current was applied.
Assessment of Thermal Hyperalgesia
Animals were placed on a glass plate, and a radiant heat (Plantar Test Apparatus, Ugo Basile, Milan, Italy) was applied to the plantar surface of the left hind paw. The withdrawal latency and duration were recorded; the minimum stimulus duration was set to 0.1 seconds, and the maximum value (cutoff latency) to 30 seconds to avoid paw injury. Each rat was tested three times at five-minute intervals, and the mean values were used for analysis.
Assessment of Mechanical Hyperalgesia
Animals were placed in a chamber, and a servo-controlled mechanical stimulus (Dynamic Plantar Aesthesiometer, Ugo Basile, Milan, Italy) was applied to the plantar surface of the hind paw at five-minute intervals with increasing punctate pressure until the rat withdrew its paw. Both hind paws were assessed in turn. The maximum cutoff force was set to 50 g to prevent tissue damage. The threshold was assessed three times for each time point, and the mean values were used for analysis.
Western Blotting
For the Western blot study, the ipsilateral dorsal horns of L4-L6 spinal cord segments were homogenized in a lysis buffer. Protease inhibitor (Sigma, MO, USA) was added to prevent protein degradation. The protein content of the supernatant was determined by BCA protein assay (Pierce, Rockford, IL, USA). Protein samples were separated on SDS-PAGE gel and transferred to nitrocellulose blots. The blots were then blocked with 5% milk and incubated overnight at 4 C with rabbit polyclonal antibody against KCC2 (Abcam, Cambridge, MA, USA) and mouse monoclonal antibody against GAPDH (Santa Cruz Biotechnology, CA, USA). Blots were further incubated with horseradish peroxidase-conjugated secondary antibody for one hour at room temperature. Color molecular weight standard markers were run on each gel. Western blot results were quantified by densitometry analysis.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation (ChIP) was performed with antibodies against acetyl-H3K9/27 (Cosmo Bio) or acetyl-H4K5/8/12/16 (Upstate) HDAC1-8 and HDAC11 (Cell Signaling Technology) as described previously [18] . Spinal cord slices were cut into 2 mm pieces, crosslinked with 1% formaldehyde, and stored in -80 C before use. Nuclei were extracted, lysed, and sonicated using a microtip until the DNA fragments were reduced to 200-1000 bp in length. Dynal protein-G beads (40 mL, Invitrogen) were preincubated with 3 mg antibody for at least six hours. Immunoprecipitation was then performed overnight at 4 C with antibody-conjugated protein-G beads. DNA/protein complexes were eluted from the beads and reverse cross-linked at 65 C overnight.
The DNA was purified with RNase A and proteinase K, followed by phenol/chloroform extraction and ethanol precipitation. Real-time quantitative polymerase chain reaction (QPCR) was performed in an iCycler using iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA). The amount of immunoprecipitated DNA was calculated in comparison with the total input DNA. Data were derived from four independent amplifications. The values of the control samples obtained from vehicletreated rats were set to 1.0, and others were expressed as fold changes relative to the controls.
Spinal Cord Slice Preparations and Whole-Cell Recordings
The lumbar spinal cord was removed under isoflurane anesthesia from naïve adult or CFA rats. Six hundred fifty lm thick transverse slices with an attached L4 or L5 root (10-20 mm) were cut on a vibrating microslicer [19] . Slices were perfused with oxygenated Krebs (10 mL/min; 36 6 1 C; in mM: NaCl 117, KCl 3.6, CaCl 2 2.5, MgCl 2 1.2, NaH 2 PO 4 1.2, NaHCO 3 25, and D-glucose 11), and whole cell patch-clamp recordings were made from lamina II neurons. Graded intensity dorsal root stimulation sufficient to recruit A beta, A delta, and C-fibers was applied with a suction electrode linked to a constant current stimulator, and evoked EPSCs and IPSCs were recorded in lamina II neurons voltage clamped to -70 or 0 mV, respectively. EPSCs were classified as monosynaptic if response latency remained constant with high-frequency (20 Hz) stimulation. Synaptic currents were amplified using an Axopatch 200A (Axon Instruments). Signals were filtered at 2 kHz and digitized at 5 kHz. Data were collected using pCLAMP (Axon Instruments) and analyzed using pCLAMP and Minianalysis software (Synaptosoft).
Statistical Analysis
All data in the study were expressed as the mean 6 standard deviation. One-way analysis of variance (ANOVA) was applied to compare the data using SPSS16.0 software (SPSS Inc., Chicago, IL, USA). Newman-Keuls post hoc test was applied for comparisons between groups. P values of less than 0.05 were considered statistically significant.
Results
CFA-Induced Mechanical Hypersensitivity Was Markedly Decreased by PRF Close to DRG
A single injection of CFA into the plantar surface of a rat hind paw produces a profound and prolonged increase in sensitivity to both thermal and mechanical stimulation [9, 10] . In CFA plantar-injected animals (N ¼ 25), the baseline mechanical paw withdrawal threshold (MPWT) was 21.4 6 2.4 g, and this decreased by 65, 73, 75, 83, and 75% at zero hours, four hours, one day, three days, seven days, and 14 days after CFA injection, respectively (P < 0.05) ( Figure 1A ). There was a decrease in the thermal paw withdrawal latency (TPWL) in the injected paw at one day postinjection (P < 0.05), which lasted for the entire 14-day testing period (P < 0.05) ( Figure 1B) . The application of PRF close to DRG in CFA rats reduced paw hypersensitivity to mechanical stimulation, and some effect on paw sensitivity was observed with thermal stimulation. In CFA rats, no-PRF applied close to DRG (N ¼ 5) had no effect on ipsilateral MPWT ( Figure 1A ). By contrast, CFA rats receiving PRF close to DRG (N ¼ 5) showed significant increases in the ipsilateral MPWT compared with no-PRF rats. MPWT continued to increase throughout the 14-day testing period ( Figure 1A) . A statistically significant difference in ipsilateral TPWL was observed between the PRF-treated group and no-PRF group hind paws at three days post-PRF treatment ( Figure 1B ).
KCC2 Protein and Acetyl H3/H4 Levels in the KCC2 Promoter Are Decreased in Spinal Cord Following CFA
Spinal cords from CFA rats were harvested at zero hours, four hours, one day, three days, seven days, and 14 days after CFA injection, and KCC2 expression levels were analyzed by Western blots. Western blotting analysis showed that protein levels of KCC2 were significantly decreased following CFA from days 1 to 14 compared with control, whereas the housekeeping gene GAPDH showed no difference (Figure 2 and Supplementary Figure 1) . These results confirmed that the KCC2 gene was downregulated in the spinal cord following CFA injection.
Levels of histone H3/H4 acetylation (acetyl-H3/H4) were measured by ChIP study, and ChIP-enriched DNA samples were analyzed by QPCR. Levels of both acetyl-H3 ( Figure 3A ) and acetyl-H4 ( Figure 3B ) at the KCC2 Figure 1 Effect of L5 and L6 pulsed radiofrequency (PRF) treatment on mechanical hypersensitivity (A) and thermal hypersensitivity (B) in complete Freund's adjuvant (CFA) rats. The mechanical withdrawal threshold and thermal withdrawal threshold in CFA rats were significantly lower than that in saline rats. PRF alleviates CFA-induced mechanical hypersensitivity (at time points from 1 day through 14 days) and thermal hypersensitivity (at 3 days; N ¼ 5 in each group). Data are mean 6 SD, *P < 0.05 for the comparison with the CFA rats receiving sham treatment (CFA þ noPRF). CFA ¼ complete Freund's adjuvant; NS ¼ normal saline; PRF ¼ pulsed radiofrequency. promoter were significantly reduced in livers from CFA rats from one to 14 days and four hours to three days, respectively, compared with controls. These results suggest that CFA-induced downregulation of KCC2 may be caused, at least in part, by a loss of activated epigenetic histone modifications at the promoter.
Decreased KCC2 Protein and Acetyl H3/H4 Levels Are Partially Reversed in Spinal Cord from CFA Rats Receiving DRG PRF PRF close to DRG, which increases histone acetylation, increased the CFA-reduced H3 acetylation level in the KCC2 promoter region from one day through 14 days after CFA injection ( Figure 3A) . DRG PRF also increased CFA-reduced H4 acetylation levels in the KCC2 promoter region from seven days to 14 days after CFA injection ( Figure 3B ). KCC2 levels also partially reversed the CFA-reduced KCC2 level in the spinal cord from one day through 14 days ( Figure 2 ).
DRG PRF Prevents Glycinergic Disinhibition and Amplifies GABAergic Inhibition
In lamina II neurons from CFA-injected rats, we found that GlyR-induced sIPSCs were similar to those in controls at four hours after injection (acute pain) but significantly smaller in amplitude at three days after injection (persistent pain). This resulted in a decrease of synaptic inhibitory charge carried by GlyR (Figure 4 , see Area) that was partially prevented by PRF close to DRG. We also characterized GABAAR sIPSCs in spinal cord slices of CFA-injected rats (N ¼ 8), treated or not with PRF. As shown in Figure 4 , the mean decay time constant and inhibitory current charge (area) of GABAAR sIPSCs were significantly increased in lamina II neurons recorded from PRF-treated CFA rats compared with the shamtreated group. Thus, persistent pain decreases presynaptic function of inhibitory synapses in lamina II neurons.
As in the above results of CFA reducing the acetylation of KCC2 promoter and KCC2 expression, treatment with PRF augmented inhibitory neurotransmission, increasing the GlyR-induced sIPSCs and GABAAR sIPSCs in neurons from CFA-injected rats.
This suggests that KCC2 expression is important for spinal inhibitory neurotransmission and that its epigenetic repression by inflammatory pain decreases (and augments by PRF) spinal inhibitory synaptic transmission.
Discussion
We made some intriguing findings in this study; firstly, the application of PRF adjacent to DRG results in a significant increase in CFA-induced decreased KCC2 protein, and acetyl H3/H4 levels are partially reversed in the spinal cords of CFA rats. Secondly, PRF treatment prevents glycinergic disinhibition and amplifies GABAergic inhibition.
It is generally believed that application of electrical stimulation, and perhaps electromagnetic stimulation, generates an electrical disruption of sensory input to elicit its analgesic effect. In addition, evidence has accumulated in animal studies demonstrating that modulation of spinal gene expression facilitates a wide range of analgesic effects in different pain systems [9, 10, 20, 21] . In this study, we have shown that the application of electromagnetic energy applied adjacently to DRG provides pain relief and, more importantly, these changes are associated with modulation of pain regulatory gene expression through chromatin modification.
Epigenetics is the study of genetic control by factors other than an individual's DNA sequence. DNA methylation and chromatin modification are critical for maintaining distinct gene expression states [22, 23] . Another study suggested that persistent inflammatory and neuropathic pain epigenetically suppresses Gad2 (encoding glutamic Figure 3 Histone H3 (A) and H4 (B) acetylation at KCC2 promoter were assessed by chromatin immunoprecipitation. Immunoprecipitated DNA and input DNA were subjected to quantitative polymerase chain reaction (QPCR) with primers specific to the indicated gene promoters to measure enrichment levels. QPCR data were analyzed using the 2ÀDDCt method, and results normalized to input DNA were expressed as fold over respective untreated rats (day 0). Data are the mean 6 SD. *P < 0.05 vs saline (N ¼ 5). CFA ¼ complete Freund's adjuvant; NS ¼ normal saline; PRF ¼ pulsed radiofrequency. acid decarboxylase 65 [GAD65]) transcription through histone deacetylase (HDAC)-mediated histone hypoacetylation [24] . The influences of environmental factors such as drug-persistent stimuli, electromagnetic on the gene expression, sometimes lead to phenotype change.
The overall results in this study revealed that PRF has effects (at least short-term) on gene expression and chromatin. This clearly indicates that this mechanism, which does not alter DNA sequence, is very important and very active in pain management at the molecular level. Greater gene expression modulation could have been observed in the spinal cord for both the CFA injection and PRF therapy at later times after PRF treatment. These results indicate a potential influence of PRF on the patient's epigenome clinically. Future research may be boosted by the expanding use of next-generation DNA-sequencing technologies [25] . Applications include chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq)-to assess the genomic distribution of histone modifications, histone variants, and nuclear proteins-and global DNA methylation analysis through the sequencing of bisulphite-converted genomic DNA. Combined with appropriate statistical and bioinformatic tools [26] , these methods will permit the identification of all the loci that are epigenetically altered. These changes seem an ideal target because they are by nature reversible, unlike DNA sequence mutations. The most popular of these treatments aims to alter either DNA methylation or histone acetylation. The limitation is that it is difficult to target the specific neurons; otherwise, activating the pronociceptive neurons or suppressing pro-analgesic neurons could make the pain conditions even worse, so the treatments could cause the very disorders they are trying to counteract.
In conclusion, this is the first animal study to treat inflammatory pain with PRF and observe not only behavioral changes but also concurrent epigenetic modulation in KCC2. The results indicate that changes in H3 acetylation of KCC2 promoter were accentuated by PRF treatment and augmented the spinal inhibitory neurotransmission. The evidence supporting that electromagnetic fields applied to the spinal nerve adjacent to DRG can modulate synaptic neurotransmission may create new alternative therapies for the management of inflammatory pain conditions and provide a research paradigm for understanding the mechanisms of pain and analgesia. As more of the mechanism behind electromagnetic stimulation is understood, pain states selection for treatment will become more optimized, thus making PRF a more viable clinical option.
Supplementary Data
Supplementary Data may be found online at http:// painmedicine.oxfordjournals.org.
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